MAUDE adverse event: Philips Medical Systems Nederland B.V. - IntelliSpace Cardiovascular

Reported to the FDA Sep 7, 2026 (event Mar 24, 2026). The FDA publishes these reports weeks after receipt. Philips reviewed the reported complaint requesting ISCV design such that there is no direct connection required to database from thick client.Based on the results of the investigat